Who Supplies Ezetimibe? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Ezetimibe exports, with 169+ registered manufacturers shipping to buyers across 85+ countries — yet a handful of companies dominate the shipments. PIRAMAL PHARMA LIMITED holds the largest share at 60.1% (export value: $309.1M). Close behind, ALKEM LABORATORIES LIMITED (20.4%, $104.9M). INTAS PHARMACEUTICALS LIMITED (2.2%, $11.5M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Ezetimibe? Top Manufacturers & Their Buyers
Flow of Ezetimibe from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Ezetimibe Supplier Network — Key Market Intelligence
The Ezetimibe export market from India is led by PIRAMAL PHARMA LIMITED, which alone commands a 60.1% share, shipping $309.1M worth of product across 269 shipments. The second-largest exporter, ALKEM LABORATORIES LIMITED, contributes $104.9M (20.4%) to the overall market. Combined, the top two suppliers alone account for 80.5% of all Ezetimibe exports, indicating a relatively concentrated supply base.
Across all 169 tracked manufacturers, the total Ezetimibe export value stands at $514.5M from 5.0K shipments. The market average shipment value is $102.2K. The single largest buyer relationship in terms of trade value is DAIICHI SANKYO EUROPE GMBH, receiving $199.1M worth of product.
The combined buyer network spans 22 named purchasing companies, including DAIICHI SANKYO EUROPE GMBH, PCI PHARMA SERVICES, DAIICHI SANKYO BRASI, ASCEND LABORATORIES LLC, PHARMACOR PTY LTD.,. and 17 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1PIRAMAL PHARMA LIMITED
PIRAMAL PHARMA LIMITED is the first-largest Ezetimibe exporter from India, with a market share of 60.1% and a total export value of $309.1M across 269 shipments. Their average shipment value of $1.1M is above the market average of $102.2K, suggesting premium or bulk contract pricing.
PIRAMAL PHARMA LIMITED serves 5 named buyers in our database. DAIICHI SANKYO EUROPE GMBH is the dominant customer, accounting for 64.4% of this supplier's tracked business. Top customers include:
• DAIICHI SANKYO EUROPE GMBH — $199.1M across 173 shipments (64.4% of this supplier's total exports)
• PCI PHARMA SERVICES — $108.2M across 94 shipments (35.0% of this supplier's total exports)
• DAIICHI SANKYO BRASI — $818.0K across 1 shipments (0.3% of this supplier's total exports)
• DAIICHI SANKYO EUROPE GMBH — $590.3K across 1 shipments (0.2% of this supplier's total exports)
• PCI PHARMA SERVICES — $368.6K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: PIRAMAL PHARMA LIMITED's per-shipment value of $1.1M is 1024% above the market average of $102.2K, consistent with large-order contracts or value-added formulations.
2ALKEM LABORATORIES LIMITED
ALKEM LABORATORIES LIMITED is the second-largest Ezetimibe exporter from India, with a market share of 20.4% and a total export value of $104.9M across 389 shipments. Their average shipment value of $269.7K is above the market average of $102.2K, suggesting premium or bulk contract pricing.
ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. ASCEND LABORATORIES LLC is the dominant customer, accounting for 94.7% of this supplier's tracked business. Top customers include:
• ASCEND LABORATORIES LLC — $99.4M across 368 shipments (94.7% of this supplier's total exports)
• ASCEND LABORATORIES LLC — $4.0M across 15 shipments (3.8% of this supplier's total exports)
• PHARMACOR PTY LTD.,. — $678.3K across 3 shipments (0.6% of this supplier's total exports)
• ASCEND GMBH — $501.0K across 2 shipments (0.5% of this supplier's total exports)
• ASCEND LABORATORIES LLC — $366.3K across 1 shipments (0.3% of this supplier's total exports)
Key Insight: ALKEM LABORATORIES LIMITED's per-shipment value of $269.7K is 164% above the market average of $102.2K, consistent with large-order contracts or value-added formulations.
3INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the third-largest Ezetimibe exporter from India, with a market share of 2.2% and a total export value of $11.5M across 333 shipments. Their average shipment value of $34.5K is below the market average of $102.2K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. NEXTPHARMA LOGISTIC GMBH is the dominant customer, accounting for 58.2% of this supplier's tracked business. Top customers include:
• NEXTPHARMA LOGISTIC GMBH — $6.7M across 194 shipments (58.2% of this supplier's total exports)
• ACCORD HEALTHCARE PTE LTD — $2.7M across 78 shipments (23.3% of this supplier's total exports)
• TO THE ORDER — $912.9K across 26 shipments (7.9% of this supplier's total exports)
• ACCORD HEALTHCARE SDN BHD — $639.7K across 19 shipments (5.6% of this supplier's total exports)
• STANDARD CHARTERED B — $567.6K across 16 shipments (4.9% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (333 shipments) at a per-shipment value of $34.5K, indicating a broad distribution network with many smaller, regular orders.
4MEDREICH LIMITED
MEDREICH LIMITED is the fourth-largest Ezetimibe exporter from India, with a market share of 1.9% and a total export value of $9.9M across 406 shipments. Their average shipment value of $24.4K is below the market average of $102.2K, reflecting a high-volume, competitive pricing strategy.
MEDREICH LIMITED serves 5 named buyers in our database. BGP PRODUCTS GMBH is the dominant customer, accounting for 76.0% of this supplier's tracked business. Top customers include:
• BGP PRODUCTS GMBH — $7.5M across 309 shipments (76.0% of this supplier's total exports)
• BGP PRODUCTS GMBH — $2.2M across 91 shipments (22.4% of this supplier's total exports)
• ABBOTT LABORATORIES — $69.1K across 3 shipments (0.7% of this supplier's total exports)
• ABBOT LABORATORIES P — $46.1K across 2 shipments (0.5% of this supplier's total exports)
• MEDREICH PLC — $42.4K across 2 shipments (0.4% of this supplier's total exports)
Key Insight: MEDREICH LIMITED operates with high shipment frequency (406 shipments) at a per-shipment value of $24.4K, indicating a broad distribution network with many smaller, regular orders.
5MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fifth-largest Ezetimibe exporter from India, with a market share of 1.2% and a total export value of $6.0M across 246 shipments. Their average shipment value of $24.3K is below the market average of $102.2K, reflecting a high-volume, competitive pricing strategy.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• VIATRIS BV C/O LIVLINA, — $2.8M across 114 shipments (46.2% of this supplier's total exports)
• CSP MYLAN SAS AT CSP LABO 274 — $1.2M across 50 shipments (20.4% of this supplier's total exports)
• CSP VIATRIS SANT? AT — $826.0K across 34 shipments (13.8% of this supplier's total exports)
• MYLAN IRELAND C/O AL — $608.1K across 25 shipments (10.2% of this supplier's total exports)
• CSP VIATRIS SANTE AT — $566.7K across 23 shipments (9.5% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (246 shipments) at a per-shipment value of $24.3K, indicating a broad distribution network with many smaller, regular orders.
6SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Ezetimibe exporter from India, with a market share of 1.0% and a total export value of $5.0M across 191 shipments. Their average shipment value of $26.3K is below the market average of $102.2K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 62.4% of this supplier's tracked business. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $3.1M across 119 shipments (62.4% of this supplier's total exports)
• M/S. RANBAXY PHARMAC — $678.9K across 26 shipments (13.5% of this supplier's total exports)
• M/S. RANBAXY (MALAYS — $507.2K across 19 shipments (10.1% of this supplier's total exports)
• M/S. RANBAXY PHARMAC — $486.3K across 18 shipments (9.7% of this supplier's total exports)
• M/S. RANBAXY (MALAYS — $216.1K across 8 shipments (4.3% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (191 shipments) at a per-shipment value of $26.3K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Ezetimibe Flows
Once Ezetimibe leaves the manufacturing plants of companies like PIRAMAL PHARMA LIMITED and ALKEM LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $514.5M. United States absorbs the largest share at 44.9% ($231.1M), followed by Germany (41.4%) and Netherlands (4.0%).
In United States — the top destination — named importers include PCI PHARMA SERVICES, ASCEND LABORATORIES LLC, ASCEND LABORATORIES,LLC. In Germany, key buyers are DAIICHI SANKYO EUROPE GMBH, NEXTPHARMA LOGISTIC GMBH, MICRO LABS GMBH.
This geographic spread reflects Ezetimibe's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Ezetimibe Go? Top Importing Countries & Their Buyers
Trade flow of Ezetimibe exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Ezetimibe imports from India, with a total trade value of $231.1M across 313 shipments — representing a 44.9% share of all Ezetimibe exports. The average shipment value of $738.4K is above the global average of $102.2K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Ezetimibe importers in United States: PCI PHARMA SERVICES is the largest buyer, accounting for 47.2% ($109.0M) of this market's total imports.
• PCI PHARMA SERVICES — $109.0M (47.2% of United States's total)
• ASCEND LABORATORIES LLC — $99.8M (43.2% of United States's total)
• ASCEND LABORATORIES,LLC — $6.7M (2.9% of United States's total)
Key Insight: United States's per-shipment average of $738.4K (622% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Ezetimibe imports from India.
2Germany
Germany ranks as the second-largest destination for Ezetimibe imports from India, with a total trade value of $213.0M across 272 shipments — representing a 41.4% share of all Ezetimibe exports. The average shipment value of $783.0K is above the global average of $102.2K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Ezetimibe importers in Germany: DAIICHI SANKYO EUROPE GMBH is the largest buyer, accounting for 94.0% ($200.3M) of this market's total imports.
• DAIICHI SANKYO EUROPE GMBH — $200.3M (94.0% of Germany's total)
• NEXTPHARMA LOGISTIC GMBH — $7.2M (3.4% of Germany's total)
• MICRO LABS GMBH — $2.6M (1.2% of Germany's total)
Key Insight: Germany's per-shipment average of $783.0K (666% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Ezetimibe imports from India.
3Netherlands
Netherlands ranks as the third-largest destination for Ezetimibe imports from India, with a total trade value of $20.3M across 566 shipments — representing a 4.0% share of all Ezetimibe exports. The average shipment value of $35.9K is below the global average of $102.2K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Ezetimibe importers in Netherlands: BGP PRODUCTS GMBH is the largest buyer, accounting for 80.4% ($16.4M) of this market's total imports.
• BGP PRODUCTS GMBH — $16.4M (80.4% of Netherlands's total)
Key Insight: Netherlands receives frequent, smaller shipments of Ezetimibe — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Netherlands is a key market for Ezetimibe imports from India.
4Australia
Australia ranks as the fourth-largest destination for Ezetimibe imports from India, with a total trade value of $6.8M across 25 shipments — representing a 1.3% share of all Ezetimibe exports. The average shipment value of $271.9K is above the global average of $102.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ezetimibe importers in Australia: APOTEX PTY LIMITED is the largest buyer, accounting for 19.6% ($1.3M) of this market's total imports.
• APOTEX PTY LIMITED — $1.3M (19.6% of Australia's total)
Key Insight: Australia's per-shipment average of $271.9K (166% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Ezetimibe imports from India.
5Belgium
Belgium ranks as the fifth-largest destination for Ezetimibe imports from India, with a total trade value of $6.8M across 104 shipments — representing a 1.3% share of all Ezetimibe exports. The average shipment value of $65.3K is below the global average of $102.2K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Ezetimibe importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 49.9% ($3.4M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $3.4M (49.9% of Belgium's total)
• VIATRIS BV C/O LIVLINA, — $2.8M (40.6% of Belgium's total)
Key Insight: Belgium receives frequent, smaller shipments of Ezetimibe — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Belgium is a key market for Ezetimibe imports from India.
People Also Ask — Ezetimibe Supplier & Trade Network
Who are the top suppliers of Ezetimibe from India?+
Which companies buy Ezetimibe from Indian manufacturers?+
Where does Ezetimibe exported from India go?+
What is the market share of the top Ezetimibe supplier from India?+
What is the average shipment value for Ezetimibe exports from India?+
Is Ezetimibe manufactured in India and exported globally?+
Which country imports the most Ezetimibe from India?+
Who are the buyers of Ezetimibe in Germany?+
How concentrated is the Ezetimibe supplier market in India?+
How do I find verified buyers for Ezetimibe in specific countries?+
Ezetimibe Trade Network — Key Takeaways
- 1PIRAMAL PHARMA LIMITED is India's dominant Ezetimibe exporter with a 60.1% market share and $309.1M in total exports — making it the single most important sourcing entity in this market.
- 2The top 169 suppliers collectively account for 86.8% of all tracked Ezetimibe exports, with a combined trade value of $514.5M.
- 3United States is the largest destination market, absorbing 44.9% of India's Ezetimibe exports ($231.1M). Germany (41.4%) and Netherlands (4.0%) follow.
- 4With 5.0K total shipments averaging $102.2K each, the Ezetimibe export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include DAIICHI SANKYO EUROPE GMBH, PCI PHARMA SERVICES, ASCEND LABORATORIES LLC, ASCEND LABORATORIES LLC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 85 countries
Network value: $514.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ezetimibe — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ezetimibe.
- 2.Flow Mapping: 169 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 5,033 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 85 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,033 Verified Shipments
169 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists